Cargando…
The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center
BACKGROUND: The 2018 International Federation of Gynecology and Obstetrics (FIGO) staging guideline for cervical cancer includes stage IIIC recognized by preoperative radiology (IIIC-r) to state there are lymph nodes metastases (LNM) identified by imaging tools. We aim to explore the reasonability a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912513/ https://www.ncbi.nlm.nih.gov/pubmed/33639874 http://dx.doi.org/10.1186/s12885-021-07890-w |
_version_ | 1783656594071879680 |
---|---|
author | Yang, E Huang, Shuying Ran, Xuting Huang, Yue Li, Zhengyu |
author_facet | Yang, E Huang, Shuying Ran, Xuting Huang, Yue Li, Zhengyu |
author_sort | Yang, E |
collection | PubMed |
description | BACKGROUND: The 2018 International Federation of Gynecology and Obstetrics (FIGO) staging guideline for cervical cancer includes stage IIIC recognized by preoperative radiology (IIIC-r) to state there are lymph nodes metastases (LNM) identified by imaging tools. We aim to explore the reasonability and limitations of stage IIIC-r and try to explore the potential reasons. METHODS: Electronic medical records were used to identify patients with cervical cancer. According to the new staging guidelines, patients were reclassified and assigned into five cohorts: stage I, stage II, stage IIIC-r, LNM confirmed by pathology (IIIC-p) and LNM detected by radiology and confirmed by pathology (IIIC r + p). Five-year overall survivals were estimated for each cohort. The diagnosis accuracy of computed tomography (CT), magnetic resonance imaging (MRI) and diameter of detected lymph nodes were also evaluated. RESULTS: A total of 619 patients were identified. The mean follow-up months were 65 months (95% CI 64.43–65.77) for all patients. By comparison, the 5-year overall survival rates were not statistically different (p = 0.21) among stage IIIC-r, stage I and stage II. While, the rates were both statistical different (p<0.001) among stage IIIC-p, IIIC r + p and stage I and stage II. The sensitivities of CT and MRI in detecting LNM preoperatively were 51.2 and 48.8%. The mean maximum diameter of pelvic lymph nodes detected by CT cohort was 1.2 cm in IIIC-r cohort, and was 1.3 cm in IIIC r + p cohort. While, the mean maximum diameter of pelvic lymph nodes detected by MRI was 1.2 cm in IIIC-r cohort, and was 1.48 cm in IIIC r + p cohort. When the diagnosis efficacy of the diameter of pelvic lymph nodes in detecting LNM were evaluated, the area under the receiver operating characteristic curve (ROC curve) was 0.58 (p = 0.05). CONCLUSIONS: It seems that the FIGO 2018 staging guideline for cervical cancer is likely to has certain limitations for the classification of those with LNM. CT or MRI, however, has limitations on detecting LNM. It would be better to use more accurate imaging tools to identify LNM in the clinical practices. |
format | Online Article Text |
id | pubmed-7912513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79125132021-03-02 The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center Yang, E Huang, Shuying Ran, Xuting Huang, Yue Li, Zhengyu BMC Cancer Research Article BACKGROUND: The 2018 International Federation of Gynecology and Obstetrics (FIGO) staging guideline for cervical cancer includes stage IIIC recognized by preoperative radiology (IIIC-r) to state there are lymph nodes metastases (LNM) identified by imaging tools. We aim to explore the reasonability and limitations of stage IIIC-r and try to explore the potential reasons. METHODS: Electronic medical records were used to identify patients with cervical cancer. According to the new staging guidelines, patients were reclassified and assigned into five cohorts: stage I, stage II, stage IIIC-r, LNM confirmed by pathology (IIIC-p) and LNM detected by radiology and confirmed by pathology (IIIC r + p). Five-year overall survivals were estimated for each cohort. The diagnosis accuracy of computed tomography (CT), magnetic resonance imaging (MRI) and diameter of detected lymph nodes were also evaluated. RESULTS: A total of 619 patients were identified. The mean follow-up months were 65 months (95% CI 64.43–65.77) for all patients. By comparison, the 5-year overall survival rates were not statistically different (p = 0.21) among stage IIIC-r, stage I and stage II. While, the rates were both statistical different (p<0.001) among stage IIIC-p, IIIC r + p and stage I and stage II. The sensitivities of CT and MRI in detecting LNM preoperatively were 51.2 and 48.8%. The mean maximum diameter of pelvic lymph nodes detected by CT cohort was 1.2 cm in IIIC-r cohort, and was 1.3 cm in IIIC r + p cohort. While, the mean maximum diameter of pelvic lymph nodes detected by MRI was 1.2 cm in IIIC-r cohort, and was 1.48 cm in IIIC r + p cohort. When the diagnosis efficacy of the diameter of pelvic lymph nodes in detecting LNM were evaluated, the area under the receiver operating characteristic curve (ROC curve) was 0.58 (p = 0.05). CONCLUSIONS: It seems that the FIGO 2018 staging guideline for cervical cancer is likely to has certain limitations for the classification of those with LNM. CT or MRI, however, has limitations on detecting LNM. It would be better to use more accurate imaging tools to identify LNM in the clinical practices. BioMed Central 2021-02-27 /pmc/articles/PMC7912513/ /pubmed/33639874 http://dx.doi.org/10.1186/s12885-021-07890-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Yang, E Huang, Shuying Ran, Xuting Huang, Yue Li, Zhengyu The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center |
title | The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center |
title_full | The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center |
title_fullStr | The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center |
title_full_unstemmed | The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center |
title_short | The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center |
title_sort | 5-year overall survival of cervical cancer in stage iiic-r was little different to stage i and ii: a retrospective analysis from a single center |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912513/ https://www.ncbi.nlm.nih.gov/pubmed/33639874 http://dx.doi.org/10.1186/s12885-021-07890-w |
work_keys_str_mv | AT yange the5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter AT huangshuying the5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter AT ranxuting the5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter AT huangyue the5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter AT lizhengyu the5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter AT yange 5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter AT huangshuying 5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter AT ranxuting 5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter AT huangyue 5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter AT lizhengyu 5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter |